Trade Summary

3 days ago, Ryan Arthur F, serving as Dir at Regeneron Pharmaceuticals, Inc. (REGN), sold 100 shares at $777.27 per share, for a total transaction value of $77,727.00. Following this transaction, Ryan Arthur F now holds 17,603 shares of REGN.

This sale represents a 1.00% decrease in Ryan Arthur F's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, April 1, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 3, 2026, 2 days after the trade was made.

Regeneron Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.